Literature DB >> 5831732

Mercaptopurine in the treatment of steroid-resistant nephrotic syndrome.

M A Shearn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5831732     DOI: 10.1056/NEJM196510282731801

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Membranous glomerulonephritis: rapidly fatal course.

Authors:  W H Tu; M A Shearn; J C Lee
Journal:  Calif Med       Date:  1967-06

2.  Management of the nephrotic syndrome.

Authors:  G C Arneil
Journal:  Arch Dis Child       Date:  1968-04       Impact factor: 3.791

3.  Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.

Authors:  K N Drummond; D A Hillman; J H Marchessault; W Feldman
Journal:  Can Med Assoc J       Date:  1968-03-16       Impact factor: 8.262

4.  [Clinical findings and prognosis of kidney manifestations in systemic lupus erythematosus].

Authors:  W Hartl; R Roos; E Genth
Journal:  Klin Wochenschr       Date:  1970-06-15

5.  Cyclophosphamide for nephrotic syndrome in children.

Authors: 
Journal:  Br Med J       Date:  1969-03-15

6.  Nephrotic syndrome in adults.

Authors: 
Journal:  Br Med J       Date:  1969-05-31

7.  Immunosuppressive therapy in persistent glomerulonephritis.

Authors: 
Journal:  Br Med J       Date:  1966-10-08

8.  Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.

Authors:  R H White; J S Cameron; J R Trounce
Journal:  Br Med J       Date:  1966-10-08

9.  Refractory nephrotic syndrome.

Authors:  R K Chandra
Journal:  Indian J Pediatr       Date:  1966-11       Impact factor: 1.967

Review 10.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.